BOSTON (Reuters) -- Irish drugmaker Elan Corp Plc (ELN.I) gave away more than it told investors in its recent $1.5 billion transaction with healthcare conglomerate Johnson & Johnson (JNJ.N)
BOSTON (Reuters) -- Irish drugmaker Elan Corp Plc (ELN.I) gave away more than it told investors in its recent $1.5 billion transaction with healthcare conglomerate Johnson & Johnson (JNJ.N)